http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20040080112-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d8e536d29b314b47fae459a962dc65e0
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-606
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-414
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-416
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-125
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-82
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-34
filingDate 2003-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b484b4e3840a8cb4f714e11c653cf2a
publicationDate 2004-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20040080112-A
titleOfInvention Manufacture Method for Durg release controlled /Eluting using biocompatibility polymer Coated stents
abstract The present invention relates to a cardiovascular stent that is inserted into a constriction in a blood vessel to compress a block, and more particularly, to the development of a long-term topical drug administration system for the prevention of restenosis.n n n In addition, the present invention separates the manufacturing process of the coating stent into the mixing process of the biocompatible polymer and the coating process on the stent support (substrate), applying the coating composition to the stent support continuously using a stirred chamber and the drug is uniform in the coating layer It is effective to manufacture a controlled release coated stent distributed.n n n The drug can be released slowly through the process of diffusion and particle dissolution through the pores between the networks in the polymer matrix, and in this way, the most effective drug release period can be controlled, which significantly lowers the restenosis rate after the procedure. It relates to a coating method and a coating liquid preparation method.n n n (Short description of drawing)n n n 1 is a perspective view showing a cardiovascular stent of the present inventionn n n Figure 2 is a simplified view showing the coating process of the present inventionn n n Figure 1n n n n n n n n Figure 2
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100888219-B1
priorityDate 2003-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA6QP91
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF1PKH2
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506983
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP26617
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ99PS1
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP83906
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP15691
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492855
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCC0K3N4
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCH0ZCS4
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474234
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506484
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6167
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555769
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF6ZYQ1
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCC0K3N5
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9MYV3
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP67860
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410506103
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF6U272
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505412
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF1NNP2
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17220
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID105034
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP67964
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453034310
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP16612
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCE1BNK3
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452871655
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP50412
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP67965
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7272
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF1R741
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557772
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ00731
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5472
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53232
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID196
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP15692
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87730705
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ66I23
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A3Q2TVI4
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448976716
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A286ZV08
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5531
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP49151
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9GKR0
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF6QDM7
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID516892
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF1PI70
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCH0YX95

Total number of triples: 74.